OCUGEN, INC. Increase (Decrease) in Accounts Payable, Related Parties
OCUGEN, INC. (OCGN) reported Increase (Decrease) in Accounts Payable, Related Parties of -$360.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2019-03-22
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2017-09-30 was $0.00.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2017-03-31 was -$360.00K, a 1261.29% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for fiscal 2017 was -$360.00K, a 374.81% decline from fiscal 2016.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for fiscal 2016 was $131.00K, a 37.91% decline from fiscal 2015.
- OCUGEN, INC. increase (decrease) in accounts payable, related parties for fiscal 2015 was $211.00K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $0.00 derived: sum of 2 quarters · filed 2019-03-22 | $0.00 derived: sum of 3 quarters · filed 2019-03-22 | -$360.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | -$360.00K 10-Q · filed 2018-11-08 | -$135.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$360.00K 10-Q · filed 2018-08-09 | -$135.00K derived: sum of 3 quarters · filed 2018-08-09 | -$269.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$360.00K 10-Q · filed 2018-05-10 | -$135.00K derived: sum of 2 quarters · filed 2018-05-10 | -$269.00K derived: sum of 3 quarters · filed 2018-05-10 | -$260.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $91.00K derived: sum of 2 quarters · filed 2018-03-15 | $100.00K derived: sum of 3 quarters · filed 2018-03-15 | $131.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$125.00K derived: sum of 2 quarters · filed 2017-11-09 | -$94.00K 10-Q · filed 2017-11-09 | -$136.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $40.00K 10-Q · filed 2017-08-10 | -$2.00K derived: sum of 3 quarters · filed 2017-08-10 | $137.00K derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $31.00K 10-Q · filed 2017-05-11 | -$11.00K derived: sum of 2 quarters · filed 2017-05-11 | $128.00K derived: sum of 3 quarters · filed 2017-05-11 | $16.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $97.00K derived: sum of 2 quarters · filed 2017-03-16 | -$15.00K derived: sum of 3 quarters · filed 2017-03-16 | $211.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $27.00K derived: sum of 2 quarters · filed 2016-11-10 | $253.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $114.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $226.00K 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |